Ajm300 (DrugBank: -)
1 diseaseID | Disease name (Link within this page) | Number of trials |
---|---|---|
97 | Ulcerative colitis | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT03531892 (ClinicalTrials.gov) | June 6, 2018 | 9/5/2018 | A Study to Evaluate the Safety and Efficacy of AJM300 in Participants With Active Ulcerative Colitis | Phase III Study of AJM300 in Patients With Active Ulcerative Colitis | Colitis, Ulcerative | Drug: AJM300;Drug: Placebo | EA Pharma Co., Ltd. | Kissei Pharmaceutical Co., Ltd. | Recruiting | 16 Years | 74 Years | All | 198 | Phase 3 | Japan |